Advancing Innovation for Patients

Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.

Investing in the future of healthcare

Guided by Helsinn’s core values of quality, integrity and respect, Helsinn Investment Fund aims to help companies with innovative technologies transform new ideas into commercial solutions with the potential to positively impact health-related quality of life.

"The Helsinn Group has been working in healthcare for more than 40 years and this fund demonstrates the commitment we have to improving health for patients around the world"
The Helsinn Group Mission

Who do we invest in?

The Helsinn Investment Fund focuses on privately-owned companies with early stage technologies in Cancer Supportive Care, Cancer Diagnostics and Cancer Therapeutics, among other areas close to Helsinn’s interests such as dermatology, metabolism and gastro-intestinal disease. These technologies range from biotech to pharma, medical devices and food supplements.

As well as these investments, Helsinn International Services, Sarl, has signed collaboration agreements with Centre Scientifique de Monaco and Lyfebulb U.S.

Therapeutics
Diagnostics
Medical Devices

Meet the Helsinn Investment Fund Board of Directors

Helsinn has a strong heritage in building successful and profitable companies; we are committed to providing innovative technology companies with the opportunity to influence the future of healthcare.

News